Authors:
Morris, LF
Wilder, MS
Waxman, AD
Braunstein, GD
Citation: Lf. Morris et al., Reevaluation of the impact of a stringent low-iodine diet on ablation rates in radioiodine treatment of thyroid carcinoma, THYROID, 11(8), 2001, pp. 749-755
Citation: Lf. Morris et al., The nonimpact of thyroid stunning: Remnant ablation rates in I-131-scannedand nonscanned individuals, J CLIN END, 86(8), 2001, pp. 3507-3511
Citation: Mr. Drange et al., Uncoupled prolactin suppression and tumor shrinkage in bromocriptine-treated prolactinomas, ENDOCRINOLO, 10(1), 2000, pp. 69-73
Citation: Lf. Morris et al., Accuracy considerations when using early (four- or six-hour) radioactive iodine uptake to predict twenty-four-hour values for radioactive iodine dosage in the treatment of Graves' disease, THYROID, 10(9), 2000, pp. 779-787
Authors:
Shifren, JL
Braunstein, GD
Simon, JA
Casson, PR
Buster, JE
Redmond, GP
Burki, RE
Ginsburg, ES
Rosen, RC
Leiblum, SR
Caramelli, KE
Mazer, NA
Jones, KP
Daugherty, CA
Citation: Jl. Shifren et al., Transdermal testosterone treatment in women with impaired sexual function after oophorectomy, N ENG J MED, 343(10), 2000, pp. 682-688
Authors:
Ren, SG
Seliktar, T
Li, X
Hershman, JM
Braunstein, GD
Melmed, S
Citation: Sg. Ren et al., In vivo and in vitro regulation of thyroid leukemia inhibitory factor (LIF): Marker of hypothyroidism, J CLIN END, 84(8), 1999, pp. 2883-2887